Global Antidiabetics Market will grow at a CAGR of more than 9.5% during the forecast period by 2022 - PowerPoint PPT Presentation

Loading...

PPT – Global Antidiabetics Market will grow at a CAGR of more than 9.5% during the forecast period by 2022 PowerPoint presentation | free to download - id: 81a57e-N2ZkY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Global Antidiabetics Market will grow at a CAGR of more than 9.5% during the forecast period by 2022

Description:

The global antidiabetics market was valued at USD 41,305.7 million in 2013 and is expected to grow at a CAGR of more than 9.5% during the forecast period. – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Antidiabetics Market will grow at a CAGR of more than 9.5% during the forecast period by 2022


1
Global Antidiabetics Market Research Report
  • Presented By
  • Market Research Engine
  • http//marketresearchengine.com/

2
Report Title Global Antidiabetics Market will
grow at a CAGR of more than 9.5 during the
forecast period by 2022
3
  • New York, May 29 Market Research Engine has
    published a new report titled as Antidiabetics
    Market - Global Industry Analysis, Size, Share,
    Growth, Trends, and Forecast 2015 - 2022
  • Ant diabetics are the drugs which stabilize the
    glucose levels in blood. These medicines also
    control and lower the levels of glucose in blood
    for diabetic patients. Most common type of
    antidiabetics is insulin. A periodic shot of
    insulin generally long acting type is prescribed
    for diabetic patients to regulate glucose
    levels. 
  • Browse Full Report http//www.marketresearchengi
    ne.com/reportdetails/antidiabetics-market
  • Increasing number of diabetic patients is
    increasing the demand for antidiabetics which is
    a driving factor for antidiabetics market.
    Increased use of insulin is a growth factor for
    this market. Insulin leads the global market with
    the largest market share by revenue and
    anticipated to have sharp growth. Increase in
    rates of obesity is obliquely driving the
    antidiabetics market. North America hold the
    largest share in antidiabetics market as it holds
    highest rate of obesity in the world, which is
    one of the major reason for cause of diabetics.

4
  • The global antidiabetics market was valued at USD
    41,305.7 million in 2013 and is expected to grow
    at a CAGR of more than 9.5 during the forecast
    period.
  •  
  • The global antidiabetics market is segmented
    based on its product which includes
    thiazolodinediones, glp-agonists, sulphonylureas,
    dpp-4 inhibitors, sglt-2, alpha-glucosidase
    inhibitors, biguanides and meglitinides. The
    insulin is segmented as rapid acting, long
    acting, premixed, premixed analog, short acting
    and intermediate acting. The market segments in
    terms of geographical regions include North
    America, Europe, Asia-Pacific and Rest of the
    World (ROW).
  • This report provides 
  • 1) An overview of the global market for
    antidiabetics and related technologies.
  •  
  • 2) Analyses of global market trends, with data
    from 2013, estimates for 2014 and 2015, and
    projections of compound annual growth rates
    (CAGRs) through 2023.
  • 3) Identifications of new market opportunities
    and targeted promotional plans for acetic acid
    market.

5
  • 4) Discussion of research and development, and
    the demand for new products and new applications.
  •  
  • 5) Comprehensive company profiles of major
    players in the industry. 
  •  
  • REPORT SCOPE 
  • The scope of the report includes a detailed study
    of global and regional markets for various types
    of coatings with the reasons given for variations
    in the growth of the industry in certain regions.
  • The report covers detailed competitive outlook
    including the market share and company profiles
    of the key participants operating in the global
    market. Key players profiled in the report
    include Sanofi-Aventis, Eli Lilly, Oramed
    Pharmaceuticals, Boehringer Ingelheim, Merck
    Co. Inc., Bristol-Myers Squibb, Novo Nordisk,
    Halozyme Therapeutics, Pfizer and Takeda
    Pharmaceuticals. Company profile includes assign
    such as company summary, financial summary,
    business strategy and planning, SWOT analysis and
    current developments. 

6
  • The Antidiabetics Market has been segmented as
    below  
  •  
  • By Types of Insulin
  •  
  • Rapid Acting
  • Long Acting
  • Premixed
  • Premixed Analog
  • Short Acting
  • Intermediate Acting
  • By Product
  •  
  • Biguanides
  • Thiazolodinediones
  • GLP-agonists
  • Sulphonylureas

7
  • DPP-4 inhibitors
  • SGLT-2
  • Alpha-glucosidase Inhibitors
  • Meglitinides
  • By Geography
  •  
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (ROW)

8

  • Table of Contents
  • TABLE OF CONTENT
  • Chapter 1. Executive Summary
  • 1.1. AntidiabeticsIndustry Summary and Critical
    Success Factors (CSFs)
  • Chapter2. Antidiabetics Industry Outlook
  • 2.1. Market Segmentation
  • 2.2. Market sizeand growth prospects
  • 2.3. Antidiabetics Market dynamics
  • 2.3.1. Market driver analysis
  • 2.3.1.1 Growing prevalence of diabetes
  • 2.3.1.2 Presence of a strong product pipeline
    portfolio
  • 2.3.1.3 Growing prevalence of lifestyle induced
    disorderssuch as obesity
  • 2.3.2. Market Restraint Analysis
  • 2.3.2.1. High insulin prices
  • 2.4. KeyOpportunities Prioritized
  • 2.5. IndustryAnalysis Porters

9
  • 2.7 Antidiabeticsmarket Pipeline overview
  • Chapter3 . Antidiabetics Product Outlook
  • 3.1. Antidiabeticsmarket share by product, 2013
    2020
  • 3.2. Insulin
  • 3.2.1. Insulin market share, by product, 2013
    2020
  • 3.2.2. Rapid acting analog market
  • 3.2.2.1. Rapid acting analog market, 2012 2020
    (USDMillion)
  • 3.2.3. Long acting analog market
  • 3.2.3.1 Long acting analog market, 2012 2020
    (USD Million)
  • 3.2.4. Premixed analog market
  • 3.2.4.1 Premixed analog market, 2012 2020 (USD
    Million)
  • 3.2.5. Premixed insulin market
  • 3.2.5.1. Premixed insulin market, 2012 2020
    (USD Million)
  • 3.2.6. Short acting insulin market
  • 3.2.6.1. Short acting insulin market, 2012
    2020 (USDMillion)
  • 3.2.7. Intermediate acting insulin market
  • 3.2.7.1 Intermediate acting insulin market, 2012
    2020 (USDMillion)
  • 3.3. Otherantidiabetics

10
  • 3.5. Biguanides
  • 3.5.1. Biguanides market, 2012 2020 (USD
    Million)
  • 3.6. Sulphonylureas
  • 3.6.1. Sulphonylureas market, 2012 2020 (USD
    Million)
  • 3.7. GLP 1 (Glucagon like peptide) agonists
  • 3.7.1. GLP 1 agonist market, 2012 2020 (USD
    Million)
  • 3.8. DPP - 4(Dipeptyl peptides) inhibitors
  • 3.8.1. DPP-4 market, 2012 2020 (USD Million)
  • 3.9. Meglitinides
  • 3.9.1. Meglitinidesmarket, 2012 2020 (USD
    Million)
  • 3.10. SGLT - 2(sodium glucose transport
    proteins) inhibitors
  • 3.10.1. SGLT - 2 inhibitors market, 2012 2020
    (USD Million)
  • 3.11. Thiazolodinediones
  • 3.11.1. Thiazolodinediones market, 2012 2020
    (USD Million)
  • Chapter4. Antidiabetics Regional Outlook
  • 4.1. Antidiabeticsmarket share, by region, 2013
    2020
  • 4.2. North America antidiabetics market
  • 4.2.1. North America antidiabetics market, 2012
    2020 (USD Million)

11
  • 4.4. Asia Pacificantidiabetics market
  • 4.4.1. Asia Pacific antidiabetics Market, 2015
    2023(USD Million)
  • 4.5. RoWantidiabetics market
  • 4.5.1. RoW antidiabetics market, 2015 2023 (USD
    Million)
  • Chapter5. Competitive Landscape
  • 5.1 Sanofi Aventis
  • 5.1.1Company Overview
  • 5.1.2Financial Performance
  • 5.1.3Product Benchmarking
  • 5.1.4Strategic Initiatives
  • 5.2 TakedaPharmaceuticals
  • 5.2.1Company Overview
  • 5.2.2Financial Performance
  • 5.2.3Product Benchmarking
  • 5.2.4Strategic Initiatives
  • 5.3 Eli Lilly
  • 5.3.1Company Overview
  • 5.3.2Financial Performance

12
  • 5.4 OramedPharmaceuticals Inc.
  • 5.4.1Company Overview
  • 5.4.2Financial Performance
  • 5.4.3Product Benchmarking
  • 5.4.4Strategic Initiatives
  • 5.5 Merck Co. Inc.
  • 5.5.1Company Overview
  • 5.5.2Financial Performance
  • 5.5.3Product Benchmarking
  • 5.5.4Strategic Initiatives
  • 5.6 Novo Nordisk
  • 5.6.1Company Overview
  • 5.6.2 FinancialPerformance
  • 5.6.3Product Benchmarking
  • 5.6.4Strategic Initiatives
  • 5.7 Bristol-Myers Squibb
  • 5.7.1Company Overview
  • 5.7.2Financial Performance
  • 5.7.3Product Benchmarking

13
  • 5.8.1Company Overview
  • 5.8.2Financial Performance
  • 5.8.3Product Benchmarking
  • 5.8.4Strategic Initiatives
  • 5.9 Pfizer
  • 5.9.1Company Overview
  • 5.9.2Financial Performance
  • 5.9.3Product Benchmarking
  • 5.9.4Strategic Initiatives
  • Check Out Other Research Reports
  • 5G Technology Market - Global Industry Analysis,
    Size, Share, Growth, Trends and Forecast 2015 -
    2023 http//www.marketresearchengine.com/reportdet
    ails/5g-technology-market
  • Acetic Acid Market for VAM, PTA, Acetate Esters,
    Acetic Anhydride and Other Applications - Global
    Industry Analysis, Size, Share, Growth, Trends
    and Forecast, 2015 - 2023 http//www.marketresearc
    hengine.com/reportdetails/acetic-acid-market

14
  • About Market Research Engine
  • Market Research Engine is a global market
    research and consulting organization. We provide
    market intelligence in emerging, niche
    technologies and markets. Our market analysis
    powered by rigorous methodology and quality
    metrics provide information and forecasts across
    emerging markets, emerging technologies and
    emerging business models. Our deep focus on
    industry verticals and country reports help our
    clients to identify opportunities and develop
    business strategies.
  • More info http//marketresearchengine.com/
  • Media Contact
  • Name John Bay
  • Toll Free No. 1-855-984-1862
  • Phone 91-860-565-7204
  • Email john_at_marketresearchengine.com
  • Website http//marketresearchengine.com/
About PowerShow.com